Skip to main content
. 2020 Feb 3;12(2):121. doi: 10.3390/pharmaceutics12020121

Table 3.

ABN401 remaining in oral gavage formulation after 8 days of incubation.

Incubation in Cold Chamber at 2–8 °C
Concentration (mg/mL) pH Day Recovery (%) SD
0.03 4.0 0 100.0 0.4
133 0 98.0 0.4
0.03 4.0 8 97.0 0.4
133 8 98.0 0.4
0.03 3.0 8 96.5 1.0
133 8 94.4 2.2
0.03 2.0 8 104.4 0.6
133 8 94.8 2.1